β cell replacement therapy for the cure of diabetes

Joonyub Lee; Kun Ho Yoon

doi:10.1111/jdi.13884

β cell replacement therapy for the cure of diabetes

Joonyub Lee
, Kun Ho Yoon

Division of Endocrinology & Metabolism

The Catholic University of Korea, College of Medicine

Research output: Contribution to journal › Review article › peer-review

12 Scopus citations

Abstract

Islet transplantation is an important option in the treatment of type 1 diabetes. However, a donor shortage and immunosuppressant-related complications are the current major hurdles of islet transplantation. In this review, we discuss recent updates on islet transplantation to overcome these current obstacles and we share our perspectives on future β cell replacement therapy.

Original language	English
Pages (from-to)	1798-1802
Number of pages	5
Journal	Journal of Diabetes Investigation
Volume	13
Issue number	11
DOIs	https://doi.org/10.1111/jdi.13884
State	Published - Nov 2022

Bibliographical note

Publisher Copyright:
© 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Keywords

Treatment-transplantation
Type 1 diabetes
β cell

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jdi.13884

Cite this

@article{e5df0eec5c784b66863234e7eca881a4,

title = "β cell replacement therapy for the cure of diabetes",

abstract = "Islet transplantation is an important option in the treatment of type 1 diabetes. However, a donor shortage and immunosuppressant-related complications are the current major hurdles of islet transplantation. In this review, we discuss recent updates on islet transplantation to overcome these current obstacles and we share our perspectives on future β cell replacement therapy.",

keywords = "Treatment-transplantation, Type 1 diabetes, β cell",

author = "Joonyub Lee and Yoon, \{Kun Ho\}",

note = "Publisher Copyright: {\textcopyright} 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley \& Sons Australia, Ltd.",

year = "2022",

month = nov,

doi = "10.1111/jdi.13884",

language = "English",

volume = "13",

pages = "1798--1802",

journal = "Journal of Diabetes Investigation",

issn = "2040-1116",

publisher = "John Wiley and Sons Inc.",

number = "11",

}

TY - JOUR

T1 - β cell replacement therapy for the cure of diabetes

AU - Lee, Joonyub

AU - Yoon, Kun Ho

PY - 2022/11

Y1 - 2022/11

N2 - Islet transplantation is an important option in the treatment of type 1 diabetes. However, a donor shortage and immunosuppressant-related complications are the current major hurdles of islet transplantation. In this review, we discuss recent updates on islet transplantation to overcome these current obstacles and we share our perspectives on future β cell replacement therapy.

AB - Islet transplantation is an important option in the treatment of type 1 diabetes. However, a donor shortage and immunosuppressant-related complications are the current major hurdles of islet transplantation. In this review, we discuss recent updates on islet transplantation to overcome these current obstacles and we share our perspectives on future β cell replacement therapy.

KW - Treatment-transplantation

KW - Type 1 diabetes

KW - β cell

UR - https://www.scopus.com/pages/publications/85135121344

U2 - 10.1111/jdi.13884

DO - 10.1111/jdi.13884

M3 - Review article

C2 - 35818819

AN - SCOPUS:85135121344

SN - 2040-1116

VL - 13

SP - 1798

EP - 1802

JO - Journal of Diabetes Investigation

JF - Journal of Diabetes Investigation

IS - 11

ER -

β cell replacement therapy for the cure of diabetes

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this